Wire Stories
Senju Pharmaceutical and Novaliq Enter Into License Agreement For NOV03 (Perfluorohexyloctane Ophthalmic Solution) For the Treatment of Dry Eye Disease in Japan
OSAKA, Japan & HEIDELBERG, Germany & CAMBRIDGE, Mass.–(BUSINESS WIRE)–#NOV03–Senju Pharmaceutical Co., Ltd., a researched-based Japanese pharmaceutical company focusing the field of ophthalmology,...